RecruitingNot Applicable

Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue

Belgium5 participantsStarted 2024-08-21

Plain-language summary

There are to date no studies available that have examined the effects of CAP on tumor tissue in patients. The aim of this study is to investigate these effects in patients undergoing surgery for peritoneal metastases. Tumor nodules will be treated with different durations and intensities of CAP before being surgically removed. The resected nodules will be analyzed for tumor vitality.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients with peritoneal metastases undergoing surgery (CRS, debulking), irrespective of the origin. Potential cancer types include ovarian cancer, colorectal cancer, and malignant peritoneal mesothelioma * Written informed consent * Age ≥ 18 years.

What they're measuring

- Histology:

Timeframe: 1 year

Trial details

NCT IDNCT06796634

SponsorUniversity Hospital, Ghent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-01

Contact for this trial

Wim Ceelen, professor

+3293326251 wim.ceelen@ugent.be

View on ClinicalTrials.gov More Cold Atmospheric Plasma (CAP) trials